Shaping new paths in clinical trial design to address alcohol use disorders and alcohol-associated liver disease,Nature Reviews Gastroenterology & Hepatology

当前位置： X-MOL 学术 › Nat. Rev. Gastroenterol. Hepatol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Shaping new paths in clinical trial design to address alcohol use disorders and alcohol-associated liver disease
Nature Reviews Gastroenterology & Hepatology ( IF 45.9 ) Pub Date : 2024-06-07 , DOI: 10.1038/s41575-024-00948-7
Juliana Serrazina _{1,

2} , Helena Cortez-Pinto _{1,

2}

Affiliation

An expert panel has proposed 28 recommendations for the design and conduct of clinical trials for alcohol use disorders and alcohol-associated liver disease. This field has a scarcity of clinical trials, despite alcohol abuse and alcohol-related liver disease being one of the greatest causes of morbidity and mortality worldwide.

中文翻译：